Metraipolis › archive › dc_ed0bb03df0e7

Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes — Europe PMC PMID:42079786

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42079786
DOI
10.1016/j.waojou.2026.101390
License (as archived)
solo-consultazione
Archived
2026-11-03T05:19:14.938Z
SHA-256 of the archived text
327358b46d21eb9e1db1c78660b10c48957c9fe57870d28daa9b0e136b1baae8
Stable URL of this page
https://metraipolis.com/documento/dc_ed0bb03df0e7

How to cite

Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes — Europe PMC PMID:42079786 — Europe PMC (en), https://europepmc.org/article/MED/42079786 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed0bb03df0e7 (Metraipolis archive dc_ed0bb03df0e7, sha256 327358b46d21eb9e1db1c78660b10c48957c9fe57870d28daa9b0e136b1baae8)
BibTeX
@misc{dced0bb03df0e7,
  title = {Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes — Europe PMC PMID:42079786},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42079786},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed0bb03df0e7; sha256 327358b46d21eb9e1db1c78660b10c48957c9fe57870d28daa9b0e136b1baae8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42079786. Agents can read the archived copy with the MCP tool read_document.